艾伯森周二提升了年度销售预测，并超出第一季度预期，依靠竞争性定价策略在通胀压力下维持了杂货店和药店的需求稳定。与其他零售商面临的需求疲软不同，美国杂货商如艾伯森和克罗格正吸引价值导向的消费者，推动同店销售预测上调。然而，艾伯森股价下跌5%，因公司维持年度调整后利润展望不变，且第一季度毛利率从去年同期的27.8%降至27.1%，这源于配送和处理成本上升以及投资支出增加。
分析师担忧公司管理通胀成本的能力，包括劳动力支出，同时还需投资于客户价值和缩小价格差距。多家企业，如零售巨头沃尔玛，已避免提供预测或撤回展望，以应对关税压力。艾伯森现在预计年度同店销售增长在2%至2.75%之间，高于之前1.5%至2.5%的范围；第一季度增长达2.8%，得益于药店销售的强劲表现。分析师指出，杂货店药店因传统药房关闭而获益，消费者转向新鲜食品作为外出就餐的健康廉价替代品。
艾伯森季度销售额达248.8亿美元，略超预期的247.3亿美元；调整后每股收益为55美分，高于53美分的预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.